As the only public hospital in Australia solely dedicated to cancer, the Peter MacCallum Cancer Centre plays an extremely important role in the community. It encompasses an acute 24-hour public hospital, has five radiation therapy satellite sites across the state, and houses the largest cancer research group in Australia. Peter Mac is a major global contributor to advances in cancer prevention, diagnosis and treatment.
Each year, nearly 28,000 Victorians develop cancer and over 10,000 deaths are caused by it. Peter Mac’s mission is to minimise the impact of cancer on its patients and the community. Every year Peter Mac sees around 25,000 people with cancer, provides over 220,000 episodes of care, and cares for inpatients requiring 43,000 bed days.
Peter Mac strongly believes that treatment informed by research and research informed by treatment is the key to progressing better cancer care. With researchers and clinicians working side-by side, Peter Mac has made significant contributions to basic research, translational research and clinical trials. Peter Mac’s research program includes 27 laboratories and over 520 scientists, clinician researchers, research nurses and other health professionals involved in various aspects of cancer research.
Peter Mac’s model of treating patients with cancer is to tailor treatment to the patient. Multi-disciplinary teams are organised into 11 ‘tumour streams’ which cover different areas of the body and cancer types. Multi-disciplinary teams, consisting of medical, surgical and radiation oncologists, nurses, radiation therapists and allied health professionals, who are specialists in a tumour type, develop comprehensive and coordinated treatment plans, ensuring that patients get treatment and a team tailored to their individual needs. Its world-leading people are a big part of what makes Peter Mac a world-leading cancer centre.
Peter Mac is now poised at one of the most significant points of its history, at a time when there are significant developments in the way that cancer is detected and treated personalised therapy and the increasing roles of molecular medicines and genomics are providing a new paradigm for cancer care. Peter Mac is at the forefront of these developments. Its vision is to be the best in cancer care, accelerating discovery, translating to cures.
For more information about Peter Mac, visit http://www.petermac.org/